Clinical and Economic Consequences of Vancomycin and Fidaxomicin for the Treatment of Clostridium difficile Infection in Canada
BACKGROUND: Clostridium difficile infection (CDI) represents a public health problem with increasing incidence and severity.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2014/793532 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832553760997507072 |
|---|---|
| author | Monika Wagner Louis Lavoie Mireille Goetghebeur |
| author_facet | Monika Wagner Louis Lavoie Mireille Goetghebeur |
| author_sort | Monika Wagner |
| collection | DOAJ |
| description | BACKGROUND:
Clostridium difficile infection (CDI) represents a public health problem with increasing incidence and severity. |
| format | Article |
| id | doaj-art-7e9a9a9557b94024a2c7e356015cd90a |
| institution | Kabale University |
| issn | 1712-9532 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases and Medical Microbiology |
| spelling | doaj-art-7e9a9a9557b94024a2c7e356015cd90a2025-02-03T05:53:15ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322014-01-01252879410.1155/2014/793532Clinical and Economic Consequences of Vancomycin and Fidaxomicin for the Treatment of Clostridium difficile Infection in CanadaMonika Wagner0Louis Lavoie1Mireille Goetghebeur2LA-SER Analytica-BioMedCom, Montreal, Quebec, CanadaLA-SER Analytica-BioMedCom, Montreal, Quebec, CanadaLA-SER Analytica-BioMedCom, Montreal, Quebec, CanadaBACKGROUND: Clostridium difficile infection (CDI) represents a public health problem with increasing incidence and severity.http://dx.doi.org/10.1155/2014/793532 |
| spellingShingle | Monika Wagner Louis Lavoie Mireille Goetghebeur Clinical and Economic Consequences of Vancomycin and Fidaxomicin for the Treatment of Clostridium difficile Infection in Canada Canadian Journal of Infectious Diseases and Medical Microbiology |
| title | Clinical and Economic Consequences of Vancomycin and Fidaxomicin for the Treatment of Clostridium difficile Infection in Canada |
| title_full | Clinical and Economic Consequences of Vancomycin and Fidaxomicin for the Treatment of Clostridium difficile Infection in Canada |
| title_fullStr | Clinical and Economic Consequences of Vancomycin and Fidaxomicin for the Treatment of Clostridium difficile Infection in Canada |
| title_full_unstemmed | Clinical and Economic Consequences of Vancomycin and Fidaxomicin for the Treatment of Clostridium difficile Infection in Canada |
| title_short | Clinical and Economic Consequences of Vancomycin and Fidaxomicin for the Treatment of Clostridium difficile Infection in Canada |
| title_sort | clinical and economic consequences of vancomycin and fidaxomicin for the treatment of clostridium difficile infection in canada |
| url | http://dx.doi.org/10.1155/2014/793532 |
| work_keys_str_mv | AT monikawagner clinicalandeconomicconsequencesofvancomycinandfidaxomicinforthetreatmentofclostridiumdifficileinfectionincanada AT louislavoie clinicalandeconomicconsequencesofvancomycinandfidaxomicinforthetreatmentofclostridiumdifficileinfectionincanada AT mireillegoetghebeur clinicalandeconomicconsequencesofvancomycinandfidaxomicinforthetreatmentofclostridiumdifficileinfectionincanada |